These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9762836)

  • 1. Cell cycle proteins in glomerular disease.
    Shankland SJ
    Kidney Blood Press Res; 1998; 21(2-4):213-4. PubMed ID: 9762836
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell cycle regulatory proteins in glomerular disease.
    Shankland SJ; Al'Douahji M
    Exp Nephrol; 1999; 7(3):207-11. PubMed ID: 10352360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cell cycle proteins in Glomerular disease.
    Griffin SV; Pichler R; Wada T; Vaughan M; Durvasula R; Shankland SJ
    Semin Nephrol; 2003 Nov; 23(6):569-82. PubMed ID: 14631565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle control in glomerular disease.
    Wolf G; Shankland SJ
    Prog Cell Cycle Res; 2003; 5():71-9. PubMed ID: 14593702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology.
    Griffin SV; Hiromura K; Pippin J; Petermann AT; Blonski MJ; Krofft R; Takahashi S; Kulkarni AB; Shankland SJ
    Am J Pathol; 2004 Oct; 165(4):1175-85. PubMed ID: 15466384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
    Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
    Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique phosphorylation of vimentin filaments in glomerular epithelial cells in culture and in disease.
    Nagasawa R; Kanozawa K; Mitarai T; Inagaki M; Maruyama N
    Nephron; 1997; 77(4):373-7. PubMed ID: 9434057
    [No Abstract]   [Full Text] [Related]  

  • 8. Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease.
    Kamanna VS
    Histol Histopathol; 2002 Apr; 17(2):497-505. PubMed ID: 11962755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cyclo-oxygenase and lipoxygenase products in health and disease.
    Dunn MJ; Scharschmidt LA; Lianos EA; Konieczkowski M
    Clin Physiol Biochem; 1984; 2(2-3):91-100. PubMed ID: 6435931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen and glomerular dysfunction.
    Iwasaki K
    Xenobiotica; 1990 Sep; 20(9):909-14. PubMed ID: 2238711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Krebs in glomeruli of normal rat kidney and in compensatory hypertrophy.
    Nowinski WW; Pigoń A
    J Histochem Cytochem; 1967 Jan; 15(1):32-7. PubMed ID: 4166299
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanical stress reduces podocyte proliferation in vitro.
    Petermann AT; Hiromura K; Blonski M; Pippin J; Monkawa T; Durvasula R; Couser WG; Shankland SJ
    Kidney Int; 2002 Jan; 61(1):40-50. PubMed ID: 11786083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sestrin 2: a regulator of the glomerular parietal epithelial cell phenotype.
    Smeets B; Huber TB
    Am J Physiol Renal Physiol; 2014 Oct; 307(7):F798-9. PubMed ID: 25143460
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell cycle regulatory proteins in podocyte health and disease.
    Marshall CB; Shankland SJ
    Nephron Exp Nephrol; 2007; 106(2):e51-9. PubMed ID: 17570940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical mechanisms of glomerular dysfunction and lesions.
    Richet G
    Nihon Jinzo Gakkai Shi; 1985 Sep; 27(9):1223-8. PubMed ID: 4087542
    [No Abstract]   [Full Text] [Related]  

  • 16. Proteinuria: a review of glomerular permeability in the normal and in various disease states.
    Pollak VE; Pesce AJ
    Perspect Nephrol Hypertens; 1977; 6():155-74. PubMed ID: 320550
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of progressive nephropathies.
    Remuzzi G; Bertani T
    N Engl J Med; 1998 Nov; 339(20):1448-56. PubMed ID: 9811921
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of reactive oxygen metabolites in experimental glomerular disease.
    Shah SV
    Kidney Int; 1989 May; 35(5):1093-106. PubMed ID: 2671460
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential glomerular proteome analysis of two murine nephropathy models at onset of albuminuria.
    Blutke A; Block C; Berendt F; Herbach N; Kemter E; Amann K; Fröhlich T; Arnold GJ; Wanke R
    Proteomics Clin Appl; 2011 Jun; 5(5-6):375-81. PubMed ID: 21538912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury.
    Park SK; Kim W; Lee CH; Koh GY
    Nephron; 2000 Nov; 86(3):306-14. PubMed ID: 11096288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.